A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
Clinical trial NCT02744898 · COMPLETED
Trial details
- NCT number
- NCT02744898
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-08-17
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.